|
|
Binance |
|
|
Coinbase |
|
|
KUCOIN |
|
|
AscendEX (Formally BitMax) |
By Trader Edge at 2026-10-02 14:36
Sentiment: Negative
TLDR Amylyx stock jumped around 21% in pre-market trading after its GLP-1 drug avexitide hit both primary and secondary endpoints in a Phase 3 trial The trial showed patients had 55% fewer severe hypoglycemic events compared to placebo Mizuho raised its price target on AMLX to $30 from $24, keeping an Outperform rating Avexitide holds [...] The post Amylyx (AMLX) Stock Clears 52-Week High After GLP-1 Drug Nails Phase 3 Trial appeared first on CoinCentral. Continue reading...
Categories: Stocks
Tags: #Stocks
Source Coin Central